Trial
NCT02258880
Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Daiichi Sankyo
Collaborators
Syneos Health
Condition
Stroke
Intervention
SUN13837
Why stopped
study was stopped for business/administrative reasons and not for patient safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-20